MedLink Opens IT Development Office in Hyderabad, India
Posted on: Friday, 29 June 2007, 12:05 CDT
MedLink International, Inc. (OTCBB: MLKNA) (FRANKFURT: WM6B) announced today that it has opened a Healthcare Information Technology (HIT) development office in Hyderabad, India that will enable the continued growth of the company, increase development and cut development costs significantly.
MedLink's Hyderabad office is staffed by locally based key management, and a team of highly skilled developers with extensive health information technology experience. Hyderabad was selected as an ideal location for MedLink's development center, as the city not only has a good communication infrastructure but also hosts a fairly large portion of the R&D sector and engineering colleges as the 6th largest metropolis in India.
Ray Vuono, Chief Executive Officer of MedLink International, stated, "Not only will the new office in India increase our development capabilities dramatically and cut costs. We believe that we will be able to leverage our development assets in India in our continued strategy to make acquisitions of companies in our sector that struggle with the extensive R&D and integration costs associated with the ever evolving field of Healthcare Information Technology."
The Office is located at 4-91, # 60, Snehengar, Hubsiguda, Cybarabad, Rangareddy, India.
About MedLink International
MedLink International is a publicly held NASDAQ Bulletin Board company (OTCBB: MLKNA) (FRANKFURT: WM6B) which supplies its proprietary MedLink EHR software via a Virtual Private Network (VPN) to a network of physicians, radiology clinics and other types of medical offices. The MedLink VPN allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-Rays, CAT Scans and other patient health information. Through its VPN, MedLink offers member institutions and physicians other products and services, such as Medical Coding & Recovery, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, and video conferencing. The MedLink VPN delivers pertinent drug information from pharmaceutical companies to physicians. In addition to the physician Virtual Private Network, MedLink is also providing a consumer network displaying medical education, information and advertising on a network of digital screens installed in the waiting rooms of radiology clinics, medical laboratories, and physician offices. www.medlinkus.com
A number of statements referenced in this Release, and in interviews that have been granted, are forward-looking statements, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not statements of historical fact and may be "forward-looking statements." Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this Release may be identified through the use of words such as "expects,""will,""anticipates,""estimates,""believes," or statements indicating certain actions "may,""could," or "might" occur. Such statements reflect the current views of MedLink International with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses, and other factors. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. MedLink International does not undertake any responsibility to update the "forward-looking" statements contained in this news release. Any communications received by fax or e-mail concerning MedLink International which have not been authorized by the Company or its investor relations/media advisory firm are specifically disavowed by the Company.
Contact : MedLink International, Inc. 631-342-8800 ir@medlinkus.com
SOURCE: MedLink International, Inc.
Source: MARKET WIRE
Related Articles
- Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
- Dr. Eliseo Oreste Salinas to Join Adolor Corporation As Senior Vice President Research & Development and Chief Medical Officer
- BridgeHealth International Names Andrew Dombro, M.D., As Chief Medical Officer of Global Health Care Company
- InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
- Synvista Therapeutics Appoints Carl M. Mendel, M.D. Vice President, Clinical Development and Chief Medical Officer
- Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Norman LaFrance, M.D., As Senior Vice President, Clinical Development and Chief Medical Officer
- Isolagen, Inc. Names Sandra Calman, M.D. Vice President of Clinical Development and Chief Medical Officer
- Kosan Appoints Robert De Jager As Chief Medical Officer
- Immtech Appoints Carol Ann Olson, MD to Senior Vice President of Pharmaceutical Development and Chief Medical Officer
- Microbia Appoints Dr. Jeffrey M. Johnston As Vice President, Clinical Development and Chief Medical Officer
 |
 |
User Comments (0)
RSS Feeds